Related Experiment Video

Updated: Jul 15, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

A role of the TRAIL-TRAIL receptor system in the pathogenesis of diabetes

Mauro Vaccarezza1, Giorgio Delbello, Giorgio Zauli

  • 1Department of Health and Motor Sciences, University of Cassino, Cassino FR, Italy. m.vaccarezza@unicas.it

Acta Bio-Medica : Atenei Parmensis
|May 1, 2007
PubMed

Insights

Tumor necrosis factor alpha-Related Apoptosis-Inducing Ligand (TRAIL) impacts diabetes vascular complications. TRAIL

Area of Science:

  • Immunology and Molecular Biology
  • Endocrinology and Vascular Biology

Background:

  • The Tumor Necrosis Factor-alpha (TNF-α) superfamily includes proteins crucial for cell death, immunity, and inflammation.
  • Tumor Necrosis Factor alpha-Related Apoptosis-Inducing Ligand (TRAIL), a newer member, is implicated in apoptosis, immune regulation, and vascular biology.

Discussion:

  • This study investigates TRAIL's role in the vascular pathology of diabetes.
  • Evidence suggests TRAIL's function in vascular biology is significant in diabetes pathogenesis, particularly in late-stage vascular alterations.
  • TRAIL exhibits a dual role in diabetes, acting as both an immune modulator and a regulator of vascular wall integrity, dependent on diabetes type and stage.

Key Insights:

  • TRAIL's novel vascular functions are linked to diabetes pathogenesis.
  • The specific role of TRAIL in diabetes-related vascular changes is highlighted.
  • TRAIL's dual action as an immune modulator and vascular regulator in diabetes is a key finding.

Outlook:

  • Further research into TRAIL's mechanisms in diabetic vasculopathy is warranted.
  • Understanding TRAIL's dual role could lead to targeted therapies for diabetic vascular complications.
  • Exploring TRAIL's potential as a therapeutic target for managing diabetes-associated vascular disease.

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...